Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

During the COVID-19 pandemic, dermatology visits decreased, especially among older patients, patients of color, men, and those with chronic conditions.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Older age and existing health conditions increase COVID-19 death risk.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Minoxidil helps heart function but doesn't improve exercise ability and may cause complications.

Minoxidil helped bald patient regrow hair.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

Doctors need to be better prepared to assess and treat obesity in patients.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Seborrheic dermatitis lowers quality of life more for women, younger people, and those with more education.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Scalp skin barrier affects hair loss; personalized treatments needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Minoxidil controls blood pressure but may cause kidney damage and needs diuretics to prevent swelling.

Skin diseases significantly lower the quality of life for patients in southern Brazil, especially for younger, single, and lower-income individuals.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Hair loss patients have different microbes in hair follicles, possibly affecting hair loss.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

People with alopecia areata have higher insulin resistance.

Familial factors affect hair loss types in Koreans, with M type in men, L type in women, and paternal factors influencing male hair loss more.